Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1794-1799

  Davì, Giovanni ^c   Basili, Stefania ^c   Vieri, Marco ^c   Cipollone, Francesco ^c   Santarone, Stella ^c   Alessandri, Cesare ^c   Gazzaniga, Pierpaolo ^c   Cordova, Corrado ^c   Violi, Francesco ^a   De Luca, N ^a   Coppotelli, L ^a   Paradiso, M ^a   Bellomo, A ^a   Belogi, A ^a   Ferroni, P ^a   Pulcinelli, F ^a   Roccaforte, S ^b   Antidormi, T ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c La Sapienza ^*

Author keywords

[No Author keywords available]

Indexed keywords

11 DEHYDROTHROMBOXANE; CREATININE; PROSTAGLANDIN SYNTHASE; PROTHROMBIN; THROMBOXANE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOSIS; URINARY EXCRETION;

EID: 14444268051     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.9706026     Document Type: Article

References (28)

1. Paunesco-Podeanu, A., C. Bratu, T. Tarachiu, M. Costescu, V. Brati, and A. Bucur. 1973. Les thromboses pulmonaires qui compliquent l'insuffisance respiratoire et le coeur pulmonaire chronique. Med. Interna 25:437-444.
2. Mitchell, R. S., G. W. Silver, G. A. Det, T. L. Petty, T. W. Vincent, S. F. Ryan, and G. F. Filley. 1968. Clinical and morphologic complications in chronic airway obstruction. Am. Rev. Respir. Dis. 97:54-62.
3. Cordova, C., A. Musca, F. Violi, C. Alessandri, A. Perrone, and F. Balsano. 1985. Platelet hyperfunction in patients with chronic airways obstruction. Eur. J. Respir. Dis. 66:9-12.
4. Rostagno, C., D. Prisco, M. Boddi, and L. Poggesi. 1991. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Eur. Respir. J. 4:147-151.
5. Wedzicha, J. A., D. Syndercombe-Court, and K. C. Tan. 1991. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxemia. Thorax 46:504-507.
6. Ferroni, P., S. Basili, F. M. Pulcinelli, G. Pettirossi, C. Alessandri, F. Violi, C. Cordova, and P. P. Gazzaniga. 1994. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 5:276-277.
7. Basili, S., P. Ferroni, F. M. Pulcinelli, G. Pettirossi, M. Vieri, F. Violi, C. Alessandri, C. Cordova, and P. P. Gazzaniga. 1996. Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease. Thromb. Res. 4:279-284.
8. Patrono, C., G. Ciabattoni, and G. Davì. 1990. Thromboxane biosynthesis in cardiovascular disease. Stroke 21:130-133.
9. Patrono, C., G. Ciabattoni, F. Pugliese, A. Pierucci, I. A. Blair, and G. A. FitzGerald. 1985. Estimated rate of thromboxane secretion into the circulation of normal humans. J. Clin. Invest. 77:590-594.
10. 2 in man. Biochim. Biophys. Acta 992:66-70.
11. Christman, B. W., C. D. McPherson, J. H. Newman, G. A. King, G. R. Bernard, B. M. Groves, and J. E. Loyd. 1992. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327:70-75.
12. Armitage, P., and G. Berry. 1987. Statistical Methods in Medical Research, 2nd ed. Blackwell Scientific Publications, Oxford. 408-420.
13. Patrignani, P., P. Filabozzi, and C. Patrono. 1982. Selective, cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 69:1366-1372.
14. 2 metabolites in humans. Thromb. Res. 47:647-656.
15. Jousilahti, P., E. Vartiainen, J. Tuomilehto, and P. Puska. 1996. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 348:567-572.
16. Novak, J., J. J. Murray, J. A. Oates, and G. A. FitzGerald. 1987. Biochemical evidence of a chronic abnormality in platelets and arterial function in healthy individuals who smoke cigarettes. Circulation 76: 6-14.
17. 2 formation of human platelets by hypoxia. Prostaglandins Leukot. Med. 29:49-59.
18. Richalet, J. P., A. Hornych, C. Rathat, J. Aumont, P. Larmignat, and P. Remy. 1991. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir. Physiol. 85:205-215.
19. Shen, D., and Y. Wang. 1994. Effects of hypoxia on platelet activation in pilots. Aviat. Space Environ. Med. 65:646-648.
20. Gray, G. W., A. C. Bryan, and M. H. Freedman. 1975. Effect of altitude exposure on platelets. J. Appl. Physiol. 39:648-652.
21. Steele, P., J. H. Ellis, and H. I. Genton. 1975. Platelet survival time in severe chronic airways obstruction. Chest 67:46s-47s.
22. Johnson, T. S., J. H. Ellis, and P. Steele. 1978. Improvement of platelet survival time with oxygen in patients with chronic obstructive airways disease. Am. Rev. Respir. Dis. 117:255-257.
23. Cordova, C., A. Musca, F. Violi, A. Perrone, and C. Alessandri. 1981. Long-term oxygen and advanced chronic bronchitis. Lancet 1:1098.
24. Le-Roux, G., P. Larmignat, M. Marchal, and J. P. Richalet. 1992. Haemostasis at high altitude. Int. J. Sports Med. 13:S49-S51.
25. Gertler, J. P., D. A. Weibe, V. H. Ocasio, and W. M. Abbott. 1991. Hypoxia induces procoagulant activity in cultured human venous endothelium. J. Vasc. Surg. 13:428-433.
26. Ogawa, S., R. Sheeniwas, J. Brett, M. Clauss, M. Furie, and D. M. Stern. 1990. The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function. Br. J. Haematol. 75:517-524.
27. Alessandri, C., S. Basili, F. Violi, P. Ferroni, P. P. Gazzaniga, C. Cordova, and the C.O.B.H. Group. 1994. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb. Haemostas. 72:343-346.
28. Patrono, C., G. Dav̀, and G. Ciabattoni. 1992. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc. Med. 2:15-20.